Abstract
Non-invasive assessment of transgenic animals using bioluminescence imaging offers a rapid means of evaluating disease progression in animal models of disease. One of the challenges in the field is to develop models with robust expression to image repetitively live intact animals through solid tissues. The prostate-specific antigen (PSA) promoter is an attractive model for studying gene regulation due to its hormonal response and tissue-specificity permitting us to measure signaling events that occur within the native tissues. The use of the GAL4-VP16 activator offers a powerful means to augment gene expression levels driven by a weak promoter. We have used a two-step transcriptional amplification (TSTA) system to develop a transgenic mouse model to investigate the tissue-specificity and developmental regulation of firefly luciferase (fl) gene expression in living mice using bioluminescence imaging. We employed an enhanced prostate-specific promoter to drive the yeast transcriptional activator, GAL4-VP16 (effector). The reporter construct carries five Gal4 binding sites upstream of the fl gene. We generated a transgenic mouse model using a single vector carrying the effector and reporter constructs. The transgenic mice show prostate-specific expression as early as three weeks of age. The bioluminescence signal in the prostate is significantly higher than in other organs. We also demonstrate that blocking androgen availability can downregulate the fl expression in the prostate. The transgenic mice display normal physical characteristics and developmental behavior, indicating that the high level of GAL4 driven expression is well tolerated. These findings suggest that the GAL4-VP16 transactivator can be used to amplify reporter gene expression from a relatively weak promoter in a transgenic mouse model. The transgenic TSTA model in conjunction with other transgenic cancer models should also help to detect and track malignancies. The strategies developed will be useful for transgenic research in general by allowing for amplified tissue specific gene expression.
Similar content being viewed by others
References
KB Cleutjens HA Korput Particlevander CC Ehren-vanEekelen RA Sikes C Fasciana LW. Chung et al. (1997) ArticleTitleA 6-kb promoter fragment mimics in transgenic mice the prostate- specific and androgen-regulated expression of the endogenous prostate-specific antigen gene Mol Endocrinol 11 1256–1265
CH Contag MH Bachmann (2002) ArticleTitleAdvances in in vivo bioluminescence imaging of gene expression Annu Rev Biomed Eng 4 235–260
CH Contag D Jenkins PR Contag RS Negrin (2000) ArticleTitleUse of reporter genes for optical measurements of neoplastic disease in vivo Neoplasia 2 41–52 Occurrence Handle10.1038/sj.neo.7900079 Occurrence Handle1:CAS:528:DC%2BD3cXlsVGhtb8%3D Occurrence Handle10933067
PR Contag IN Olomu DK Stevenson CH Contag (1998) ArticleTitleBioluminescent indicators in living mammals Nat Med 4 245–247
CH Contag SD Spilman PR Contag M Oshiro B Eames P Dennery et al. (1997) ArticleTitleVisualizing gene expression in living mammals using a bioluminescent reporter Photochem Photobiol 66 523–531
A De XZ Lewis SS Gambhir (2003) ArticleTitleNoninvasive imaging of lentiviral mediated reporter gene expression in living mice Mol Ther 7 681–691
B Fang L Ji M Bouvet JA Roth (1998) ArticleTitleEvaluation of GAL4/TATA in vivo Induction of transgene expression by adenovirally mediated gene codelivery. J Biol Chem 273 4972–4975
SE Fraser RW Koster (2001) ArticleTitleTracing transgene expression in living zebrafish embryos Dev Biol 233 329–346
DP Gardner GW Byrne FH Ruddle C Kappen (1996) ArticleTitleSpatial and temporal regulation of a lacZ reporter transgene in a binary transgenic mouse system Transgenic Res 5 37–48
M Iyer L Wu M Carey Y Wang A Smallwood SS Gambhir (2001) ArticleTitleTwo-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters P Natl Acad Sci USA 98 14595–14600
PE Koch ZS Guo S Kagawa J Gu JA Roth B Fang (2001) ArticleTitleAugmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a Gal4 gene regulatory system Mol Ther 3 278–283
TF Massoud SS Gambhir (2003) ArticleTitleMolecular imaging in living subjects: seeing fundamental biological processes in a new light Gene Dev 17 545–580
DM Nettelbeck V Jerome R Muller (2000) ArticleTitleGene therapy: designer promoters for tumour targeting Trends Genet 16 174–181
DM Ornitz WM Randall P Leder (1991) ArticleTitleBinary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements P Nat Acad Sci USA 88 698–702
S Pang J Dannull R Kaboo Y Xie CI Tso K. Michel et al. (1997) ArticleTitleIdentification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen Cancer Res 57 495–499
P Ray A De JJ Min RY Tsien SS Gambhir (2004) ArticleTitleImaging tri-fusion multimodality reporter gene expression in living subjects Cancer Res 64 1323–1330
P Ray H Pimenta R Paulmurugan F Berger ME Phelps M. Iyer et al. (2002) ArticleTitleNoninvasive quantitative imaging of protein-protein interactions in living subjects P Natl Acad Sci U S A 99 3105–3110
P Ray AM Wu SS Gambhir (2003) ArticleTitleOptical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice Cancer Res 63 1160–1165
I Sadowski J Ma S Triezenberg M Ptashne (1988) ArticleTitleGAL4-VP16 is an unusually potent transcriptional activator Nature 335 563–564
ER Schuur GA Henderson LA Kmetec JD Miller HG Lamparski DR Henderson (1996) ArticleTitleProstate-specific antigen expression is regulated by an upstream enhancer J Biol Chem 271 7043–7051
Y Wang M Iyer L Wu M Carey SS Gambhir (2002) ArticleTitleA two-step transcriptional approach for imaging vascular endothelial growth factor (VEGF) gene expression using a bioluminescent reporter gene Mol Imaging Biol 4 S42
C Wei RA Willis BR Tilton RJ Looney EM Lord RK. Barth et al. (1997) ArticleTitleTissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy P Natl Acad Sci USA 94 6369–6374
L Wu J Matherly A Smallwood AS Belldegrun M Carey (2001) ArticleTitleChimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vector Gene Ther 8 1416–1426
JC Wu G Sundaresan M Iyer SS Gambhir (2001) ArticleTitleNoninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice Mol Ther 4 297–306
X Xie Z Luo KM Slawin DM Spencer (2004) ArticleTitleThe EZC-prostate model: noninvasive prostate imaging in living mice Mol Endocrinol 18 722–732
YG Yueh PJ Yaworsky C Kappen (2000) ArticleTitleHerpes simplex virus transcriptional activator VP16 is detrimental to preimplantation development in mice Mol Reprod Dev 55 37–46
L Zhang JY Adams E Billick R Ilagan M Iyer K Le et al. (2002) ArticleTitleMolecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer Mol Ther 5 223–232
J Zhang M Johnson KH Le M Sato R Ilagan M. Iyer et al. (2003) ArticleTitleInterrogating androgen receptor function in recurrent prostate cancer Cancer Res 63 4552–4560
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iyer, M., Salazar, F.B., Lewis, X. et al. Non-invasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. Transgenic Res 14, 47–55 (2005). https://doi.org/10.1007/s11248-004-2836-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11248-004-2836-1